BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Rating) was the recipient of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 1,600 shares, a drop of 65.2% from the April 30th total of 4,600 shares. Based on an average daily trading volume, of 9,800 shares, the short-interest ratio is currently 0.2 days.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in BriaCell Therapeutics stock. Privium Fund Management B.V. raised its position in BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Rating) by 16.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 318,960 shares of the company’s stock after acquiring an additional 45,306 shares during the period. Privium Fund Management B.V.’s holdings in BriaCell Therapeutics were worth $622,000 at the end of the most recent reporting period.
BriaCell Therapeutics Trading Down 1.3 %
BriaCell Therapeutics stock traded down $0.04 during midday trading on Friday, hitting $2.59. 2,162 shares of the company’s stock were exchanged, compared to its average volume of 16,649. BriaCell Therapeutics has a 12-month low of $1.60 and a 12-month high of $3.99. The firm’s 50 day simple moving average is $2.87 and its 200 day simple moving average is $2.67.
- Get a free copy of the StockNews.com research report on BriaCell Therapeutics (BCTXW)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.